
    
      The study shall be conducted according to ISO 14155. Results of this research study will be
      used to assess the performance and safety of the System and its components. Data may be
      combined with similar research at additional sites to create a greater understanding of the
      endpoints. Up to sixty (60) patients (including "roll-in" or training patients) will be
      enrolled in a non-randomized study to assess the safety and efficacy of the Ablation
      Frontiers Cardiac Ablation System. Further studies may be performed to gather additional data
      regarding the safety and efficacy of the system.

      Patients with a history of symptomatic permanent AF, willing and able to sign an informed
      consent, and meeting all inclusion/exclusion criteria, as identified by the clinical
      investigator, will be enrolled in the study. Comparative and descriptive statistics will be
      used to summarize patient outcomes for the specified study endpoints.
    
  